Data presentations underscore category leadership and expertise in dermatology and immunology MUMBAI, India and PRINCETON, N.J., March 27, 2026 /PRNewswire/ -- Sun Pharmaceutical Industries Limited ...

Younger patients with alopecia areata (AA) and those who have a history of acne were more likely to develop acne during Janus kinase inhibitor (JAKi) treatment in a study. Researchers conducted a ...

Please provide your email address to receive an email when new articles are posted on . At week 24, 17% to 28% of adolescents treated with ritlecitinib 30 mg and higher achieved the primary endpoint.

SUZHOU, China, March 21, 2023 /PRNewswire/ -- The 2023 Annual Meeting of American Academy of Dermatology Association (AAD 2023) was held from 17 to 21 March 2023 in New Orleans, Louisiana, United ...

Age-stratified outcomes favored adolescents (48.6% SALT ≤20) versus adults (21.9%), plausibly related to shorter disease duration, shorter current episode, and greater follicular regenerative capacity ...

There is a growing body of scientific evidence supporting a causal link between the gut microbiota and dermatologic conditions such as atopic dermatitis, psoriasis, acne, and alopecia areata. There is ...

The Food and Drug Administration on Monday approved a drug called baricitinib as the first for treating severe alopecia areata, an autoimmune disorder affecting more than 300,000 people in the United ...

People with a severe form of baldness will now have a significant treatment option available. On Monday, the Food and Drug Administration approved baricitinib for treating alopecia areata. The drug, ...